ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 617

$621K Total Retail Price of All Prescriptions

Rank: 43 out of 617

445 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 445 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,605 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 598 549 1 1
WARFARIN SODIUM 389 321 2 7
SIMVASTATIN 384 362 3 2
CARVEDILOL 360 340 4 19
FUROSEMIDE 337 307 5 4
AMLODIPINE BESYLATE 311 300 6 6
LISINOPRIL 311 288 6 5
METOPROLOL SUCCINATE 280 241 8 12
HYDROCODONE-ACETAMINOPHEN 275 175 S3 9 8
ATORVASTATIN CALCIUM 272 237 10 14
OMEPRAZOLE 258 217 11 3
METFORMIN HCL 258 231 11 9
RANITIDINE HCL 231 175 13 40
BENAZEPRIL HCL 217 209 14 44
CITALOPRAM HBR 212 183 15 18
METOPROLOL TARTRATE 192 177 16 11
PREDNISONE 189 169 17 31
GABAPENTIN 150 98 18 16
MIRTAZAPINE 135 123 19 50
SERTRALINE HCL 133 96 20 20
LOSARTAN POTASSIUM 123 118 21 22
PANTOPRAZOLE SODIUM 110 107 22 37
ATENOLOL 106 106 23 17
FLUOXETINE HCL 102 59 24 73
KLOR-CON 10 100 95 25 126
TAMSULOSIN HCL 99 99 26 26
CLOPIDOGREL 95 81 27 53
ALLOPURINOL 90 88 28 27
FLUTICASONE PROPIONATE 84 69 29 36
FINASTERIDE 84 84 29 104
KLOR-CON M20 80 67 31 116
ISOSORBIDE MONONITRATE ER 78 78 32 52
LEVOFLOXACIN 78 70 32 89
ADVAIR DISKUS 73 59 34 38
DIOVAN 72 58 35 41
PLAVIX 72 62 35 86
PAROXETINE HCL 71 56 37 62
ALBUTEROL SULFATE 71 22 37 112
ZOLPIDEM TARTRATE 70 52 39 23
DIGOXIN 70 60 39 48
RISPERIDONE 70 42 39 71
CLONIDINE HCL 69 55 42 55
TRAMADOL HCL 67 19 43 15
CRESTOR 64 47 44 28
BENAZEPRIL-HYDROCHLOROTHIAZIDE 63 63 45 168
LACTULOSE 62 0 46 179
LIPITOR 62 48 46 118
LYRICA 61 44 48 92
NAMENDA 61 57 48 35
POLYETHYLENE GLYCOL 3350 60 48 50 32
TRAZODONE HCL 60 56 50 51
MELOXICAM 60 55 50 24
SPIRIVA 58 46 53 61
PROAIR HFA 56 34 54 75
LANTUS 55 36 55 39
NOVOLOG 55 30 55 137
FAMOTIDINE 53 41 57 54
OXYCODONE-ACETAMINOPHEN 52 47 S2 58 93
TORSEMIDE 51 46 59 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.